GS1
Johnson & Johnson Serialization Program Case Study
Pages
2
Time to read
11 mins
Publication
Language
English
Pages
2
Time to read
11 mins
Publication
Language
English
This case study outlines Johnson & Johnson's approach to enhancing product integrity and safety through serialization in the healthcare sector. Serialization, which involves assigning unique identifiers to individual product units, is crucial in combating counterfeit drugs and ensuring traceability throughout the supply chain. The document details the challenges faced in unregulated markets, particularly in Colombia, where counterfeit products have been reported. Johnson & Johnson's proactive measures include extending serialization practices to high-risk products in regions lacking specific mandates. The implementation of the Traceability and Verification System (TRVST) is also discussed, highlighting its role in verifying the authenticity of health products in resource-limited countries. The case study emphasizes the benefits of serialization, including improved patient safety, regulatory readiness, and operational efficiency. By leveraging existing capabilities and collaborating with global health organizations, Johnson & Johnson aims to address critical challenges in the fight against counterfeit medicines and enhance supply chain visibility.